Predictive Factors for Supraclavicular Lymph Node Recurrence in N1 Breast Cancer Patients
Authors:
- Moonkyoo KongMKMoonkyoo Kong
- Seong Eon HongSHSeong Eon Hong
Open Access
- 30 April 2013
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (4) , 2509-2514
Abstract
Predictive Factors for Supraclavicular Lymph Node Recurrence in N1 Breast Cancer Patients Breast cancer;predictive factor;radiotherapy;supraclavicular lymph node recurrence; Background: The purpose of this study was to identify predictive factors for supraclavicular lymph node recurrence (SCLR) in N1 breast cancer patients and define a high-risk subgroup who might benefit from supraclavicular nodal radiotherapy (RT). Materials and Methods: From January 1995 to December 2009, 113 breast cancer patients with 1 to 3 positive axillary lymph nodes were enrolled in this study. All patients underwent breast-conserving surgery (BCS) or modified radical mastectomy (MRM). RT was given to all patients who received BCS. Among the patients given MRM, those with breast tumors >5 cm in size received RT. Regional nodal irradiation was not applied. Systemic chemotherapy was given to 105 patients (92.9%). Patient data were retrospectively reviewed and analyzed to identify predictive factors for SCLR. Results: The median follow-up duration was 6.5 years, with 5- and 10-year actuarial SCLR rates of 9.3% and 11.2%, respectively. Factors associated with SCLR on univariate analysis included histologic grade, number of dissected axillary lymph nodes, lymphovascular invasion, extracapsular extension (ECE), and adjuvant chemotherapy. On multivariate analysis, histologic grade and ECE remained significant. The patient group with grade 3 and ECE had a significantly higher rate of SCLR compared with the remainder (5-year SCLR rate; 71.4% vs. 4.0%, p<0.001). Conclusions: Histologic grade and ECE status are significant predictive factors for SCLR. Supraclavicular nodal RT is necessary in N1 breast cancer patients featuring histologic grade 3 and ECE.Keywords
This publication has 22 references indexed in Scilit:
- The Risk of Early and Late Lung Sequelae After Conformal Radiotherapy in Breast Cancer PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005Annals of Oncology, 2005
- Radiotherapy for invasive breast cancer in North America and Europe: Results of a surveyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Prognosis after regional lymph node recurrence in patients with Stage I–II breast carcinoma treated with breast conservation therapyCancer, 2003
- Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Prediction of supraclavicular lymph node metastasis in breast carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Incidence and time of occurrence of regional recurrence in stage i-ii breast cancer: value of adjuvant irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- The significance of supraclavicular fossa node recurrence after radical mastectomyCancer, 1986